View ValuationThe9 将来の成長Future 基準チェック /06現在、 The9の成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Software 収益成長16.0%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Nov 13The9 Limited, Annual General Meeting, Dec 22, 2025The9 Limited, Annual General Meeting, Dec 22, 2025, at 14:00 China Standard Time. Location: bny mellon office, room no. 2602,26/f three pacific place, 1queens road east, wanchai., Hong Kongお知らせ • Sep 23The9 Limited Announces Impersonation of the9bit on A Crypto PlatformThe9 Limited announced to the9bit community and the wider public that accounts and token listings on a crypto platform are impersonating the9bit and claiming affiliation with the9bit. These accounts and tokens are unauthorized, fraudulent, and not connected to the9bit in any way. Please note: the9bit has not launched nor endorsed any tokens on any crypto exchange yet. Currently any listings, messages, or wallets claiming to represent the9bit are scams. Do not interact with, send funds to, or otherwise engage with these impersonating listings. What the9bit is doing to protect the community: the9bit has contacted that crypto platform's legal team and their support channels to report the impersonation and are actively working with them to determine what actions can be taken to remove the fraudulent listings and prevent further abuse. the9bit is monitoring the situation closely and will share updates through the official channels.お知らせ • Apr 01The9 Limited announced that it expects to receive $8 million in funding from Bripheno Pte. Ltd. and other investorsThe9 Limited announced that it has entered into a purchase agreement to issue class A common shares for the gross proceeds of $8 million on March 31, 2025. The shares issued are subject to statutory lock-up period. The transaction will include participation from Bripheno Pte. Ltd., Elune Capital, Fine Vision Fund.お知らせ • Nov 20The9 Limited, Annual General Meeting, Dec 27, 2024The9 Limited, Annual General Meeting, Dec 27, 2024, at 14:00 China Standard Time. Location: bny mellon office, room no. 4, 26/f three pacific place, 1 queen`s road east, hong kong, ChinaBoard Change • Jun 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jun 05The9 Limited (NasdaqCM:NCTY) agreed to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $ 8.16 million.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $8.16 million on June 3, 2024. The consideration consists of $1.5 million in cash and issuance of 948,218 ADSs.お知らせ • May 25The9 Limited announced that it expects to receive $3.5 million in funding from Finewill CapitalThe9 Limited announced a private placement of class A ordinary shares for the gross proceeds of $3.5 million on May 24, 2024. The transaction will include participation from new investor, Fine Vision Fund , a fund managed by, Finewill Capital. These shares to be issued are subject to the statutory lock-up period. The invetsor will invest with upfront investment of $2.5 million and second installment of $1 million which is based on a pre-agreed condition.お知らせ • May 21The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd. on May 20, 2024. Pursuant to the Agreement, The9 will pay cash consideration of $1.5 million and will issue 318,448,800 restricted Class A ordinary shares (equivalent to 1,061,496 ADSs) to KuaiJin, which will be subject to lock-up conditions. The9 is also granted a purchase option to purchase up to 51% of the total shares of KuaiJin. The purchase option is exercisable within 2 years and will be based on KuaiJin's valuation at $60 million.お知らせ • Mar 27The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million.The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million on March 26, 2024. The consideration includes cash consideration of $1.5 million and issuance of 251.3 million restricted Class A ordinary shares equivalent to 0.84 million ADSs. Prior to the transaction, The9 Limited (NasdaqCM:NCTY) held 8.3%. The9 is also granted a purchase option to purchase up to 51% of the total shares of WM Therapeutic under certain conditions.お知らせ • Feb 22The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million.The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million on February 21, 2024.お知らせ • Nov 30The9 Limited announced that it has received $12 million in funding from Bripheno Pte. Ltd.,The9 Limited announced that it has announced a private placement of 150,000,000 class A ordinary shares at a price of $0.04 per share for the gross proceeds $6 million and two-year 3% per annum convertible promissory note at a price of $6 million and warrants for the gross proceeds of $12 million on November 30, 2023. The notes will be convertible into American depository shares with the conversion price of $15 per share and warrants to purchase an aggregate of 120,000,000 class A ordinary shares at an exercise price of $60 per ADS. The warrants will expire two years from the date of issuance. The issued securities are subject to a 6-month lock up period. The transaction will include participation from new investor, Bripheno Pte. Ltd.,お知らせ • Nov 17The9 Limited, Annual General Meeting, Dec 22, 2023The9 Limited, Annual General Meeting, Dec 22, 2023, at 14:00 China Standard Time. Location: BNY Mellon Office, Room No. 2602, 26/F Three Pacific Place 1 Queen's Road East Wanchai Hong KongNew Risk • Oct 02New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 71% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (71% increase in shares outstanding).Reported Earnings • Dec 26First half 2022 earnings released: CN¥26.75 loss per share (vs CN¥11.19 loss in 1H 2021)First half 2022 results: CN¥26.75 loss per share (further deteriorated from CN¥11.19 loss in 1H 2021). Net loss: CN¥579.7m (loss widened 361% from 1H 2021). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.お知らせ • Nov 18The9 Limited, Annual General Meeting, Dec 19, 2022The9 Limited, Annual General Meeting, Dec 19, 2022, at 14:00 China Standard Time. Location: 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai ChinaBoard Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Reported Earnings • May 04Full year 2021 earnings releasedFull year 2021 results: Revenue: CN¥135.9m (up CN¥135.2m from FY 2020). Net loss: CN¥411.2m (down 204% from profit in FY 2020).Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.Board Change • Apr 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Jun 05The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd. on June 4, 2021. According to the agreement, The9 plans to invest a total of CAD 7.6 million in Montcrypto in two phases to obtain the controlling stake in Montcrypto. The9 will pay hosting fee to Montcrypto at a rate of CAD 0.037/kWh for a period of 5 years.お知らせ • Mar 10The9 Limited to Report Fiscal Year 2020 Results on Mar 29, 2021The9 Limited announced that they will report fiscal year 2020 results on Mar 29, 2021お知らせ • Feb 23The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million.The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million on February 22, 2021. The consideration will be paid by issuing Class A ordinary shares of The9 Limited, subject to due diligence and valuation to be conducted by an independent valuation firm.お知らせ • Feb 10The9 Limited Enters into a Standby Equity Distribution Agreement with YA II PN, LTDThe9 Limited announced that it has entered into a standby equity distribution agreement with YA II PN, LTD., dated February 5, 2021, pursuant to which The9 would be able to sell up to $100.0 million of its ADSs solely at The9’s request based on The9’s funding requirement at any time during the 36 months following the date of the SEDA.お知らせ • Nov 21The9 Limited, Annual General Meeting, Dec 22, 2020The9 Limited, Annual General Meeting, Dec 22, 2020, at 14:00 China Standard Time. Location: at the 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai Chinaお知らせ • Nov 18The9 Limited Announces Receipt of Nasdaq Notice of DeficiencyThe9 Limited announced on November 17, 2020 that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated November 12, 2020, indicating that the Company no longer meets the continued listing requirement of minimum Market Value of Listed Securities ("MVLS") for the Nasdaq Capital Market, as set forth in the Nasdaq Listing Rule 5550(b)(2) because the market value of the Company's securities listed on Nasdaq for the last 30 consecutive business days was below the minimum MVLS requirement of $35.0 million. Pursuant to the Rule 5810(c)(3)(C) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until May 11, 2021 (the "Compliance Period"), to regain compliance with Nasdaq's minimum MVLS requirement. If at any time during the Compliance Period, the Company's MVLS closes at $35.0 million or more for a minimum of ten consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance with Rule 5550(b)(2) prior to the expiration of the Compliance Period, the Company will receive written notification that its securities are subject to delisting.お知らせ • Nov 05The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on November 2, 2020 stating that The9 has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the matter is now closed.お知らせ • Oct 02The9 Limited has completed a Follow-on Equity Offering.The9 Limited has completed a Follow-on Equity Offering. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 23,500,000 Price\Range: $0.37 Discount Per Security: $0.0259 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 23,500,000お知らせ • Oct 01The9 Limited announced that it expects to receive $30 million in funding from Ark Pacific Capital Management Limited, IE LimitedThe9 Limited (NasdaqGS:NCTY) announced that it has entered into a term sheet for the private placement of 25,000,000 ordinary shares at a price of $1.2 per share for gross proceeds of $30,000,000 on April 10, 2017. The transaction will include participation from existing investor Ark Pacific Special Opportunities Fund I, L.P., a fund managed by Ark Pacific Capital Management Limited and IE Limited (KOSDAQ:A023430). Each investor will subscribe for 50% of the total shares. The shares will be subject to a redemption right. The completion of the each transaction is subject to the parties execution of a definitive agreement and customary closing conditions to be stipulated therein.お知らせ • Sep 22The9 Limited and Voodoo Sign Cooperation and Publishing AgreementThe9 Limited announced that it has signed an Agreement with Voodoo. The9 and Voodoo will collaborate on the publishing and operation of casual games in mainland China. The9 will publish and operate under this agreement two, with an option for a third, casual games with strong IAP (In App Purchase) licensed by Voodoo.お知らせ • Aug 07The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on August 5, 2020 stating that The9 has regained compliance with the minimum market value of listed securities requirement under Nasdaq Listing Rule 5550(b)(2) and the matter is now closed. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、The9 は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測DB:FZK0 - アナリストの将来予測と過去の財務データ ( )CNY Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025108-402-35-32N/A9/30/202595-272N/AN/AN/A6/30/202582-143N/AN/AN/A3/31/202597-108N/AN/AN/A12/31/2024112-73-53-44N/A9/30/202413929N/AN/AN/A6/30/2024176132N/AN/AN/A3/31/2024178-3N/AN/AN/A12/31/2023174-137-48-46N/A9/30/2023159-219N/AN/AN/A6/30/2023172-739N/AN/AN/A3/31/2023145-857N/AN/AN/A12/31/2022105-689-403-154N/A9/30/202287-791N/AN/AN/A6/30/202261-865N/AN/AN/A3/31/202298-638N/AN/AN/A12/31/2021136-387-780-704N/A9/30/2021131-251N/AN/AN/A6/30/2021126-91-362-308N/A3/31/202163153-234-207N/A12/31/20201397-107-106N/A9/30/20201310-103-102N/A6/30/20201222-99-99N/A3/31/2020016-77-76N/A12/31/20190-191-55-54N/A9/30/20194-201N/AN/AN/A6/30/20197-211N/AN/AN/A3/31/201912-235N/AN/AN/A12/31/201817-258N/A-101N/A9/30/201843-191N/AN/AN/A6/30/201868-124N/AN/AN/A3/31/201870-149N/AN/AN/A12/31/201773-175N/A-87N/A9/30/201761-281N/AN/AN/A6/30/201749-386N/AN/AN/A3/31/201753-531N/AN/AN/A12/31/201656-677N/A-180N/A9/30/201651-675N/AN/AN/A6/30/201645-674N/AN/AN/A3/31/201646-529N/AN/AN/A12/31/201546-385N/A-176N/A9/30/201554-251N/AN/AN/A6/30/201561-117N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: FZK0の予測収益成長が 貯蓄率 ( 1.9% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: FZK0の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: FZK0の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: FZK0の収益がGerman市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: FZK0の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: FZK0の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YSoftware 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/07 16:42終値2026/05/07 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋The9 Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。8 アナリスト機関Eddie LeungBofA Global ResearchAlicia YapCitigroup IncDi WeiJ.P. Morgan5 その他のアナリストを表示
お知らせ • Nov 13The9 Limited, Annual General Meeting, Dec 22, 2025The9 Limited, Annual General Meeting, Dec 22, 2025, at 14:00 China Standard Time. Location: bny mellon office, room no. 2602,26/f three pacific place, 1queens road east, wanchai., Hong Kong
お知らせ • Sep 23The9 Limited Announces Impersonation of the9bit on A Crypto PlatformThe9 Limited announced to the9bit community and the wider public that accounts and token listings on a crypto platform are impersonating the9bit and claiming affiliation with the9bit. These accounts and tokens are unauthorized, fraudulent, and not connected to the9bit in any way. Please note: the9bit has not launched nor endorsed any tokens on any crypto exchange yet. Currently any listings, messages, or wallets claiming to represent the9bit are scams. Do not interact with, send funds to, or otherwise engage with these impersonating listings. What the9bit is doing to protect the community: the9bit has contacted that crypto platform's legal team and their support channels to report the impersonation and are actively working with them to determine what actions can be taken to remove the fraudulent listings and prevent further abuse. the9bit is monitoring the situation closely and will share updates through the official channels.
お知らせ • Apr 01The9 Limited announced that it expects to receive $8 million in funding from Bripheno Pte. Ltd. and other investorsThe9 Limited announced that it has entered into a purchase agreement to issue class A common shares for the gross proceeds of $8 million on March 31, 2025. The shares issued are subject to statutory lock-up period. The transaction will include participation from Bripheno Pte. Ltd., Elune Capital, Fine Vision Fund.
お知らせ • Nov 20The9 Limited, Annual General Meeting, Dec 27, 2024The9 Limited, Annual General Meeting, Dec 27, 2024, at 14:00 China Standard Time. Location: bny mellon office, room no. 4, 26/f three pacific place, 1 queen`s road east, hong kong, China
Board Change • Jun 06Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. No experienced directors. 5 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 05The9 Limited (NasdaqCM:NCTY) agreed to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $ 8.16 million.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 19% stake in Wuhan Weixiang Science And Technology Co., Ltd for $8.16 million on June 3, 2024. The consideration consists of $1.5 million in cash and issuance of 948,218 ADSs.
お知らせ • May 25The9 Limited announced that it expects to receive $3.5 million in funding from Finewill CapitalThe9 Limited announced a private placement of class A ordinary shares for the gross proceeds of $3.5 million on May 24, 2024. The transaction will include participation from new investor, Fine Vision Fund , a fund managed by, Finewill Capital. These shares to be issued are subject to the statutory lock-up period. The invetsor will invest with upfront investment of $2.5 million and second installment of $1 million which is based on a pre-agreed condition.
お知らせ • May 21The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive share purchase agreement to acquire 15% stake in Kuaijin Times (Xiamen) Technology Co.,Ltd. on May 20, 2024. Pursuant to the Agreement, The9 will pay cash consideration of $1.5 million and will issue 318,448,800 restricted Class A ordinary shares (equivalent to 1,061,496 ADSs) to KuaiJin, which will be subject to lock-up conditions. The9 is also granted a purchase option to purchase up to 51% of the total shares of KuaiJin. The purchase option is exercisable within 2 years and will be based on KuaiJin's valuation at $60 million.
お知らせ • Mar 27The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million.The9 Limited (NasdaqCM:NCTY) entered into a definitive share purchase agreement to acquire additional 21.7% stake in WM Therapeutics Co., Ltd. for approximately $6.1 million on March 26, 2024. The consideration includes cash consideration of $1.5 million and issuance of 251.3 million restricted Class A ordinary shares equivalent to 0.84 million ADSs. Prior to the transaction, The9 Limited (NasdaqCM:NCTY) held 8.3%. The9 is also granted a purchase option to purchase up to 51% of the total shares of WM Therapeutic under certain conditions.
お知らせ • Feb 22The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million.The9 Limited signed an term sheet to acquire 19% stake in Zhejiang Fazhidao Information Technology Co., Ltd. for $15.6 million on February 21, 2024.
お知らせ • Nov 30The9 Limited announced that it has received $12 million in funding from Bripheno Pte. Ltd.,The9 Limited announced that it has announced a private placement of 150,000,000 class A ordinary shares at a price of $0.04 per share for the gross proceeds $6 million and two-year 3% per annum convertible promissory note at a price of $6 million and warrants for the gross proceeds of $12 million on November 30, 2023. The notes will be convertible into American depository shares with the conversion price of $15 per share and warrants to purchase an aggregate of 120,000,000 class A ordinary shares at an exercise price of $60 per ADS. The warrants will expire two years from the date of issuance. The issued securities are subject to a 6-month lock up period. The transaction will include participation from new investor, Bripheno Pte. Ltd.,
お知らせ • Nov 17The9 Limited, Annual General Meeting, Dec 22, 2023The9 Limited, Annual General Meeting, Dec 22, 2023, at 14:00 China Standard Time. Location: BNY Mellon Office, Room No. 2602, 26/F Three Pacific Place 1 Queen's Road East Wanchai Hong Kong
New Risk • Oct 02New major risk - Shareholder dilutionThe company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 71% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). Earnings have declined by 34% per year over the past 5 years. Shareholders have been substantially diluted in the past year (71% increase in shares outstanding).
Reported Earnings • Dec 26First half 2022 earnings released: CN¥26.75 loss per share (vs CN¥11.19 loss in 1H 2021)First half 2022 results: CN¥26.75 loss per share (further deteriorated from CN¥11.19 loss in 1H 2021). Net loss: CN¥579.7m (loss widened 361% from 1H 2021). Over the last 3 years on average, earnings per share has increased by 13% per year but the company’s share price has fallen by 59% per year, which means it is significantly lagging earnings.
お知らせ • Nov 18The9 Limited, Annual General Meeting, Dec 19, 2022The9 Limited, Annual General Meeting, Dec 19, 2022, at 14:00 China Standard Time. Location: 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai China
Board Change • Nov 16Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Reported Earnings • May 04Full year 2021 earnings releasedFull year 2021 results: Revenue: CN¥135.9m (up CN¥135.2m from FY 2020). Net loss: CN¥411.2m (down 204% from profit in FY 2020).
Board Change • Apr 27Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
Board Change • Apr 15Insufficient new directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. CFO & Director George Lai was the last director to join the board, commencing their role in 2016. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Jun 05The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd.The9 Limited (NasdaqCM:NCTY) signed a definitive agreement to acquire an unknown stake in Montcrypto Ltd. on June 4, 2021. According to the agreement, The9 plans to invest a total of CAD 7.6 million in Montcrypto in two phases to obtain the controlling stake in Montcrypto. The9 will pay hosting fee to Montcrypto at a rate of CAD 0.037/kWh for a period of 5 years.
お知らせ • Mar 10The9 Limited to Report Fiscal Year 2020 Results on Mar 29, 2021The9 Limited announced that they will report fiscal year 2020 results on Mar 29, 2021
お知らせ • Feb 23The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million.The9 Limited (NasdaqCM:NCTY) entered into a binding memorandum of understanding to acquire 70% stake in Hangzhou SuanLi Technology Co., Ltd. for $7 million on February 22, 2021. The consideration will be paid by issuing Class A ordinary shares of The9 Limited, subject to due diligence and valuation to be conducted by an independent valuation firm.
お知らせ • Feb 10The9 Limited Enters into a Standby Equity Distribution Agreement with YA II PN, LTDThe9 Limited announced that it has entered into a standby equity distribution agreement with YA II PN, LTD., dated February 5, 2021, pursuant to which The9 would be able to sell up to $100.0 million of its ADSs solely at The9’s request based on The9’s funding requirement at any time during the 36 months following the date of the SEDA.
お知らせ • Nov 21The9 Limited, Annual General Meeting, Dec 22, 2020The9 Limited, Annual General Meeting, Dec 22, 2020, at 14:00 China Standard Time. Location: at the 17 Floor, No. 130 Wu Song Road, Hong Kou District Shanghai China
お知らせ • Nov 18The9 Limited Announces Receipt of Nasdaq Notice of DeficiencyThe9 Limited announced on November 17, 2020 that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market Inc. ("Nasdaq") dated November 12, 2020, indicating that the Company no longer meets the continued listing requirement of minimum Market Value of Listed Securities ("MVLS") for the Nasdaq Capital Market, as set forth in the Nasdaq Listing Rule 5550(b)(2) because the market value of the Company's securities listed on Nasdaq for the last 30 consecutive business days was below the minimum MVLS requirement of $35.0 million. Pursuant to the Rule 5810(c)(3)(C) of the Nasdaq Listing Rules, the Company has a compliance period of 180 calendar days, or until May 11, 2021 (the "Compliance Period"), to regain compliance with Nasdaq's minimum MVLS requirement. If at any time during the Compliance Period, the Company's MVLS closes at $35.0 million or more for a minimum of ten consecutive business days, Nasdaq will provide the Company a written confirmation of compliance and the matter will be closed. In the event the Company does not regain compliance with Rule 5550(b)(2) prior to the expiration of the Compliance Period, the Company will receive written notification that its securities are subject to delisting.
お知らせ • Nov 05The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on November 2, 2020 stating that The9 has regained compliance with the minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the matter is now closed.
お知らせ • Oct 02The9 Limited has completed a Follow-on Equity Offering.The9 Limited has completed a Follow-on Equity Offering. Security Name: American Depositary Shares Security Type: Depositary Receipt (Common Stock) Securities Offered: 23,500,000 Price\Range: $0.37 Discount Per Security: $0.0259 Security Name: Warrants Security Type: Equity Warrant Securities Offered: 23,500,000
お知らせ • Oct 01The9 Limited announced that it expects to receive $30 million in funding from Ark Pacific Capital Management Limited, IE LimitedThe9 Limited (NasdaqGS:NCTY) announced that it has entered into a term sheet for the private placement of 25,000,000 ordinary shares at a price of $1.2 per share for gross proceeds of $30,000,000 on April 10, 2017. The transaction will include participation from existing investor Ark Pacific Special Opportunities Fund I, L.P., a fund managed by Ark Pacific Capital Management Limited and IE Limited (KOSDAQ:A023430). Each investor will subscribe for 50% of the total shares. The shares will be subject to a redemption right. The completion of the each transaction is subject to the parties execution of a definitive agreement and customary closing conditions to be stipulated therein.
お知らせ • Sep 22The9 Limited and Voodoo Sign Cooperation and Publishing AgreementThe9 Limited announced that it has signed an Agreement with Voodoo. The9 and Voodoo will collaborate on the publishing and operation of casual games in mainland China. The9 will publish and operate under this agreement two, with an option for a third, casual games with strong IAP (In App Purchase) licensed by Voodoo.
お知らせ • Aug 07The9 Limited Regains Compliance with Nasdaq Listing RequirementThe9 Limited announced that it received a notification letter from the Nasdaq Stock Market LLC ("Nasdaq") on August 5, 2020 stating that The9 has regained compliance with the minimum market value of listed securities requirement under Nasdaq Listing Rule 5550(b)(2) and the matter is now closed.